BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 28, 2006
View Archived Issues
Reovirus may promote immune response to cancer
Read More
Studies detail intravenous safety and preclinical activity of lacosamide
Read More
Presentations outline agomelatine efficacy in treating depression
Read More
Phase II results with FTY-720 in multiple sclerosis encourage phase III program
Read More
Additional preclincal, clinical and pharmacokinetic data on denosumab presented
Read More
Seikagaku licenses inflammatory disease rights to CF-101 in Japan
Read More
Advaxis discusses phase II plans for Lovaxin C with FDA
Read More
Optimized IC-41 regimen studied in proof-of-concept trial for hepatitis C
Read More
UCB: pipeline overview
Read More
RotaTeq vaccine provided free in Nicaragua over three years
Read More
Pevion Biotech reports phase I testing of virosome-based breast cancer vaccine
Read More
ImmuFact IMP-321 studied in phase I disease-free melanoma trial
Read More
New retinoid RARgamma agonists claimed in recent Galderma patent
Read More
Pagoclone advances for stuttering, discontinued for premature ejaculation
Read More
Recent patents describe new agents for diabetes and related disorders
Read More
AT-9283 studied in phase I/II trial for hematological malignancies
Read More
Pharmacokinetics, efficacy and safety of sitagliptin in patients with type 2 diabetes
Read More
Novel compounds with potential in the treatment of metabolic disorders patented
Read More
Expanded access program opens for TMC-125
Read More
Orphan drug designation for atiprimod in carcinoid tumors
Read More
MKC-1 studied in hematological malignancies in new phase I trial
Read More
CytRx reports encouraging results from phase IIa ALS trial with arimoclomol
Read More
Remicade approved for chronic severe plaque psoriasis
Read More
Vectibix approved for metastatic colorectal cancer
Read More
Fampridine-SR meets all SPA efficacy criteria in MS walking study
Read More
New preclinical data on NXL-104, a novel beta-lactamase inhibitor
Read More
Essential oil component carvacrol may be useful in cancer and thromboembolic disorders
Read More
PBI-1308: new protein A mimetic against autoimmune diseases
Read More
Novel antioxidant compounds show benefit in a mouse model of amyotrophic lateral sclerosis
Read More
R&D highlights from the UBS Global Life Science Conference in New York: Astex Therapeutics
Read More
